参考文献/References:
[1]Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J]. Ann Thorac Surg,1996,61(2):755-759.
[2]Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention[J]. Circulation,2003,108(6):711-716.
[3]Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview[J]. Circulation,2006,114(15):1645-1653.
[4]Berger F, Vogel M, Alexi-Meskishvili V, et al. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects[J]. J Thorac Cardiovasc Surg,1999,118(4):674-678.
[5] 中国医师协会心血管内科分会先心病工作委员会. 常见先天性心脏病介入治疗中国专家共识 一、房间隔缺损介入治疗[J]. 介入放射学杂志,2011,20(1):3-9.
[6]Kirchhof P, Benussi S, Kotecha D, et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Europace,2016,18(11):1609-1678.
[7]Duong P, Ferguson LP, Lord S, et al. Atrial arrhythmia after transcatheter closure of secundum atrial septal defects in patients≥40 years of age[J]. Europace,2017,19(8):1322-1326.
[8]潘子磊, 杨荣, 孔祥清, 等. 房间隔缺损并发的心房颤动的治疗探讨[J]. 南京医科大学学报(自然科学版),2015,35(5):674-677.
[9]Nie JG, Dong JZ, Salim M, et al. Catheter ablation of atrial fibrillation in patients with atrial septal defect: long-term follow-up results[J]. J Int Cardiac Electrophysiol,2014,42(1):43-49.
[10]刘旭, 王如兴, 王新华, 等. 环肺静脉前庭电隔离对房间隔缺损合并心房颤动患者治疗方法学和疗效评价[J]. 国际心血管病杂志,2007,34(5):370-373.
[11]Sang CH, Dong JZ, Long DY, et al. Transseptal puncture and catheter ablation of atrial fibrillation in patients with atrial septal occluder:initial experience of a singel centre[J]. Europace,2018,20(9):1468-1474.
[12]黄从新, 张澍, 黄德嘉,等. 心房颤动:目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志,2018,32(04):315-368.
[13]Fountain RB, Holmes DR, Chandrasekaran K, et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial[J]. Am Heart J,2006,151(5):956-961.
[14]Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fi brillation_ a randomised non-inferiority trial[J]. Lancet, 2009, 374(9689):534-542.
[15]Reddy VY, Doshi SK, Kar S, et al. 5- year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials[J]. J Am Coll Cardiol,2017,70(24):2964-2975.
[16]Holmes DR, Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J]. J Am Coll Cardiol,2014,64(1):1-12.
[17]Boersma LV, Schmidt B, Betts TR, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry[J]. Eur Heart J,2016,37(31):2465-2474.
[18]Urena M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy[J]. J Am Coll Cardiol,2013,62(2):96-102.
[19]Kuwata S, Vierecke J, Gloekler S, et al. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation[J]. Cardiol J,2018,25(2):179-187.
[20]Song S, Lee OH, Kim JS, et al. Simultaneous closure of a left atrial appendage through an atrial septal defect and the atrial septal defect[J]. Yonsei Med J,2017,58(6):1237.
[21]姚青, 宋治远, 郭燕丽, 等. 经皮左心耳封堵术在非瓣膜性心房颤动患者中的应用——单中心经验[J]. 中国介入心脏病学杂志,2018,26(10):553-558.
[22]王建铭, 崔春生, 盛晓棠, 等. 同期行经皮左心耳封堵术与房间交通封堵术的临床研究[J]. 中国介入心脏病学杂志,2018,26(10):559-565.
[23]刘毅, 刘海涛, 武峰, 等. 房间隔联合左心耳封堵治疗房间隔缺损伴心房颤动老年患者1例[J]. 心脏杂志,2017,29(1):21-23.
[24]李丁扬, 张刚成, 沈群山, 等. 房间隔缺损伴持续性心房颤动行房间隔缺损与左心耳介入封堵术1例[J]. 中国介入心脏病学杂志,2015,23(10):581-583.
[25]崔春生, 王建铭, 朱鲜阳, 等. 左心耳封堵术治疗先天性心脏病合并房颤临床观察[J]. 临床军医杂志,2016,44(10):1087-1091.
[26]Gafoor S, Franke J, Boehm P, et al. Leaving no hole unclosed: left atrial appendage occlusion in patients having closure of patent foramen ovale or atrial septal defect[J]. J Interv Cardiol,2014,27(4):414-422.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(7):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(7):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(7):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(7):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(7):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]